Back to search

Article

GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects and Current Therapies

2020-08-05

Abstract excerpt

GM2 gangliosidoses are a group of pathologies characterized by GM2 ganglioside accumulation into the lysosome due to mutations on the genes encoding for the β-hexosaminidases subunits or the GM2 activator protein. Three GM2 gangliosidoses have been described: Tay-Sachs disease, Sandhoff disease, and the AB variant. Central nervous system dysfunction is the main characteristic of GM2 gangliosidoses patients th...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a1519c51-a894-58ff-a459-0703fa855b50
DOI
10.20944/preprints202007.0137.v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects and Current TherapiesDOI 10.20944/preprints202007.0137.v2
Select a neighboring publication to make it the new centre.